DataSheet_1_Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2.pdf by Yun Ji (464484)

Soft Actuator with Biomass Porous Electrode: A Strategy for Lowering Voltage and Enhancing Durability by Hao Zhang (15339)

Soft Actuator with Biomass Porous Electrode: A Strategy for Lowering Voltage and Enhancing Durability by Hao Zhang (15339)

Soft Actuator with Biomass Porous Electrode: A Strategy for Lowering Voltage and Enhancing Durability by Hao Zhang (15339)

The expression of tight junction proteins in intestinal wall. by Xueyan Lin (448667)

Mutation of <i>abxN</i> at the native locus is not sufficient to alter the proximal-distal bias. by Rebecca K. Delker (5683535)

Group results for Experiment 1 and 2. by Adam M. Roth (19845864)

mPEG PV1-Fab’ dampens IFN-γ production by CD4⁺ T lymphocytes. by Pedro Henrique Papotto (791904)

Suppressed expression of <i>CDS1</i> and <i>CDS2</i> resulted in the defective embryonic development. by Xin-Qiao Du (13150022)

The point mutants E559A, E563A and K567A display altered DNA-binding kinetics. by Bettina Hüntelmann (566945)

“…Whole cell extracts from STAT1-GFP-reconstituted U3A cells were incubated for 15 min with [³³P]-labelled DNA containing a single STAT binding site (M67) and, subsequently, a 750-fold molar excess of unlabelled DNA was added for 0, 5 and 10 min, respectively, before the samples were loaded onto a native polyacrylamide gel. …”

Cost-effectiveness of the BPaL treatment regimen (USD 2022). by Denise Evans (288201)

Subjects:

Direct and indirect on-treatment costs of patients accessing TB care (USD 2022) (N = 72). by Denise Evans (288201)

Subjects:

Provider costs for TB provision by clinical outcome (mean, calculated 95% CI) (USD 2022). by Denise Evans (288201)

Subjects:

Characteristics of patients included in the retrospective medical record review to assess patient resource-use (n = 112). by Denise Evans (288201)

Subjects:

Characteristics of patients included in the TB patient cost survey (N = 72). by Denise Evans (288201)

Subjects:

Summary of treatment groups and regimens. by Denise Evans (288201)

Subjects:

Catastrophic and coping costs of patients accessing TB care (USD 2022) (n = 72). by Denise Evans (288201)

Subjects:

Lessons from writing sessions: a school-based randomized trial with adolescent orphans in Rwanda by Johanna Unterhitzenberger (6931928)

Machine learning models and univariate analyses discriminating non-severe and severe COVID-19 patients. by Gamalat A. Elgedawy (18700038)

“…The vertical dashed lines refer to the cutoff that equates a log2fold change value of |1.5|.</p>…”

Machine learning models and univariate analyses discriminating HC from non-severe COVID-19 patients. by Gamalat A. Elgedawy (18700038)

“…The vertical dashed lines refer to the cutoff that equates a log2fold change value of |1.5|.</p>…”